Akèy › Obèsite › Texas › McKinney
Etid klinik pou Obèsite nan McKinney, TX
4 etid pou Obèsite ap chèche patisipan nan sit nan ak bò kote McKinney (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
Ap rekriteFaz 2
- Revival Research Institute, LLC, McKinney
- Texas Institute of Cardiology, PA, McKinney
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Ap rekriteFaz 3
- North Dallas Research Associates, McKinney
- Texas Institute of Cardiology, McKinney
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
Ap rekriteFaz 3
- Texas Institute of Cardiology, McKinney
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Ap rekriteFaz 3
- North Texas Research Associates, McKinney
Etid Obèsite nan lòt vil
- Houston, TX43 etid
- Chicago, IL41 etid
- New York City, NY40 etid
- San Antonio, TX40 etid
- Washington, DC33 etid
- Orlando, FL31 etid
- Dallas, TX30 etid
- Boston, MA28 etid
- Las Vegas, NV27 etid
- Miami, FL27 etid
- Baltimore, MD25 etid
- Jacksonville, FL25 etid
Lòt etid nan McKinney
- Ensifizyans kadyak7 etid
- Dyabèt Tip 26 etid
- Asm5 etid
- BPCO5 etid
- Maladi ren kwonik4 etid
- Maladi kadyovaskilè4 etid
- Ateroskleroz3 etid
- Maladi poumon entèstisyèl3 etid
- Maladi Graves3 etid
- Fibrilasyon atriyal3 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.